APPENDIX 1.

ICD-9-CM and ICD-10-CA codes applied to define safety outcomes.

OutcomesICD-9-CMICD-10-CA
Serious infection1,2
  Organism-specific infections001.*–139.*A00.*–A079.*
  Organ-specific infections
    Meningitis320.*, 049.*G00.*–G03.*
    Encephalitis323.*, 054.3G04.*
    CNS abscess, cranial and spinal324.*G06.*–G08.*
    Endocarditis421.*I33.*
    Bacterial pneumonia481.*–486.*J12.*–J18.*
    All respiratory infections460.*–466.*, 473.*, 480.*-487.*, 510.*, 513.*J00.*–J22.*, J85.*–J86.*
    Pyelonephritis590.*N10.*, N12.*
    Septic arthritis098.5, 711.0, 711.4–711.9M00.*–M02.*
    Osteomyelitis730.*M46.2 (vertebra), M86.*, M90.0 (TB)
    Skin/soft-tissue035.*, 680.* 681.*, 682.*, 683.*, 684.*A46.*, L00.*–L03.*
    Septicemia038.*; 790.7A40.*, A41.*
    Post-op infection998.5T81.4
    Fungal
      Aspergillosis117.3B44.*
      Candidiasis, systemic112.4–112.8B37.1, B37.5, B37.6, B37.7
      Endemic mycoses (coccidioidomycosis, histoplasmosis, blastomycosis, paracoccidioidomycosis)114.*, 115.*, 116.*B38.*, B39.*, B40.*, B41.*
    Herpes zoster 1053.*B02.*
    Tuberculosis010–18; V12.01; V01.1; 647.3A15–A19
Cancer †
  Any cancerSolid organ, primary site: 140–195
Solid organ, secondary site: 196–198
Solid organ, no site specified: 199
Lymphatic/hematopoietic: 200–208
Neuroendocrine: 209		C00–14; C15–26; C30–39; C40–41; C43–44; C45–49; C50; C51–58; C60–63; C64–68; C69–72; C73–75; C7A, C7B; C76–80; C81–96
  Lung162C33, C34
  Breast174, 175C50
  Colorectal153, 154C19, C19, C20, C21
  Lymphoproliferative200–208C81–96
Cardiovascular
  MI3410.xI21.x, I22.x
  CHF4428.xI50.x, I09.0, I11.0, I13.0, I13.2, I25.5, I42.0, I42.5–42.9; I43.x; P29.0
  CVA5
    Acute ischemic stroke362.3, 433.x1, 434.x1, 436H34.1, I63.x, I64.x
    Intracerebral hemorrhage431.xI61.x
    Subarachnoid hemorrhage430.xI60.x
    Transient ischemic attack435.xG45.x

  • ↵† Provided by S. Bernatsky. ICD-9-CM: International Classification of Diseases 9th revision, Clinical Modification; ICD-10-CA: ICD 10th revision, Canada; CNS: central nervous system; MI: myocardial infarction; CHF: congestive heart failure; CVA: cerebrovascular accident.

  • ↵1. Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J, et al. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res 2013;65:353–61.

  • ↵2. Barber C, Lacaille D, Fortin PR. Systematic review of validation studies of the use of administrative data to identify serious infections. Arthritis Care Res 2013;65:1343–57.

  • ↵3. Metcalfe A, Neudam A, Forde S, Liu M, Drosler S, Quan H, et al. Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates. Health Serv Res 2013;48(1):290–318.

  • ↵4. McCormick N, Lacaille D, Bhole V, Avina-Zubieta JA. Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLoS One 2014;9:e104519.

  • ↵5. Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10. Stroke 2005; 36:1776–81.